Precision Medicine Vision

Precision medicine is medical diagnosis, prevention and treatment based on an individual’s variation in genes, environment, and lifestyle. Knowledge of an individual’s personal genome allows us to make informed decisions about the best medical care available, for that person. From fundamental discoveries to the clinic, Columbia... Read more

Life Science Entrepreneurship Series

Best Practices starting a Biotech: Lessons learned from Industry Leaders

Precision Medicine Initiative at Columbia University was host to the inaugural Life Science Entrepreneurship seminar series. The series consisted of 4 classes, each centered around a case study exploring best practices among industry leaders. 

The objective of the seminar series was to expose graduate students and young faculty from the life science disciplines to the entrepreneurial world. The hope was that the seminar series informed and inspired the participants to consider careers in biotechnology.  The audience included graduate students, postdocs and young faculty from the life science disciplines and related faculties at the University.


Regeneron: The Path from Research to Commercial Product 
Speakers: George Yancopoulos, Leonard Schleifer
Tuesday, March 21
Topics:
From Research to Clinic Target Patient 
Value Proposition and Forecasting
Investors, Clinical Development and Regulatory Pathway
Commercial Launch
Case Study: The Regeneron story tells the challenges and key decisions that lead to one of the most successful biotechnology companies.
 

This lecture in the Columbia Precision Medicine Initiative, Life Science Entrepreneurship seminar series, features a discussion with two of Regeneron’s leadership team: President and CSO George Yancopoulos, MD, PhD, and President and CEO of Regeneron, Leonard Schleifer, MD, PhD. The panel, moderated by the Director of the Columbia Precision Medicine Initiative Tom Maniatis, PhD, covers the life-cycle of an idea from basic research to a commercially viable product with a focus on Target Patient, Value Proposition and Forecasting; Attracting Investors; Clinical Development and Regulatory Pathways.

Watch Here


From Basic Biology to the Clinic: Acceleron, Aurora BioSciences, Genetics Institute, ProScript and Scenomics

Speakers: Tom Maniatis, Charles Zucker, Tony Evnin

Tuesday, April 04, 2017

The second class From Basic Biology to the Clinic: Acceleron, Aurora BioSciences, Genetics Institute, ProScript and Scenomics will cover topics such as: Basic Biology, Clinical Application and Pre-Clinical Development, and Intellectual Property, with a special presentation from Tom Maniatis (Scientific Founder; PMI), Charles Zucker (Scientific Founder; PMI), Tony Evnin (Partner; Venrock).

This second lecture in the Columbia Precision Medicine Initiative, Life Science Entrepreneurship seminar series, features a discussion with distinguished panelists Tom Maniatis, PhD, (Director, Columbia Precision Medicine Initiative), Charles Zuker, PhD, (Professor of Biochemistry and Molecular Biophysics, CUMC), and Tony Evnin (Partner, Venrock). The panel, moderated by Tig Conger, MBA (Heritage Partners), cover topics of Basic Biology, Clinical Application and Pre-Clinical Development, and Intellectual Property.

Watch here.


Developing a Business Plan and Securing Investors
Speakers:Mark Leuchtenberger, Cameron Durrant, Ron Newbold, Lorraine Marchand 
Wednesday, May 3
Topics: A presentation of the timelines, budget and investment required to achieve key milestones  
Case Study: The Path to Getting the Company Funded and Product to Market
 

Distinguished panelists Mark Leuchtenberger, MBA (President, CEO, IRX Therapeutics), Cameron Durrant, MD, MBA (Chairman and CEO, KaloBios Pharmaceuticals), and Ron Newbold, PhD, MBA (VP, External R&D Innovation, Pfizer) discuss the development of a business plan to bring early stage technologies through clinical development and into the marketplace. This fourth lecture of the Life Science Entrepreneurship seminar series is moderated by Lorraine Marchand, MBA (Managing Partner, Centricity Health and Adjunct Professor at Columbia Business School).

Watch Here

Videos

Jonathan Pritchard 

Professor in the Departments of Genetics and Biology at Stanford University and an Investigator in the Howard Hughes Medical Institute